Article
Mutations accumulated in the Spike of SARS-CoV-2 Omicron allow for more efficient counteraction of the restriction factor BST2/Tetherin.
PLoS pathogens - 1 Jan 2024
Shi Yuhang, Simpson Sydney, Chen Yuexuan, Aull Haley, Benjamin Jared, Serra-Moreno Ruth
Abstract excerpt
BST2/Tetherin is a restriction factor with broad antiviral activity against enveloped viruses, including coronaviruses. Specifically, BST2 traps nascent particles to membrane compartments, preventing their release and spread. In turn, viruses have evolved multiple mechanisms to counteract BST2. Here, we examined the interactions between BST2 and SARS-CoV-2. Our study shows that BST2 reduces SARS-CoV-2 virion...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
